Perspective Therapeutics (CATX) News Today $3.64 +0.15 (+4.30%) Closing price 10/3/2025 04:00 PM EasternExtended Trading$3.67 +0.03 (+0.80%) As of 10/3/2025 07:25 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CATX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Perspective Therapeutics (NYSE:CATX) Given Buy Rating at HC WainwrightOctober 5 at 2:35 AM | americanbankingnews.comHC Wainwright & Co. Reiterates Perspective Therapeutics (CATX) Buy RecommendationOctober 3 at 4:43 PM | msn.comHC Wainwright Reiterates Buy Rating for Perspective Therapeutics (NYSE:CATX)October 3 at 8:21 AM | marketbeat.comPerspective Therapeutics' (CATX) Outperform Rating Reaffirmed at WedbushOctober 3 at 2:46 AM | americanbankingnews.comPerspective Therapeutics announces first patient treated with PSV359October 2 at 3:28 PM | msn.comWedbush Reaffirms "Outperform" Rating for Perspective Therapeutics (NYSE:CATX)October 2 at 10:34 AM | marketbeat.comPerspective Therapeutics Announces First Patient Dosed with PSV359 in the Second Cohort of a Phase 1/2a Study in Patients with FAP-α Positive Solid TumorsOctober 2 at 8:51 AM | finance.yahoo.comReviewing Perspective Therapeutics (NYSE:CATX) & Medifocus (OTCMKTS:MDFZF)September 29, 2025 | americanbankingnews.comPerspective Therapeutics, Inc. (NYSE:CATX) Given Average Rating of "Buy" by BrokeragesSeptember 26, 2025 | marketbeat.comGoldman Sachs Group Inc. Sells 600,099 Shares of Perspective Therapeutics, Inc. $CATXSeptember 25, 2025 | marketbeat.comPerspective Therapeutics' (CATX) Buy Rating Reaffirmed at HC WainwrightSeptember 20, 2025 | marketbeat.comPerspective Therapeutics (NYSE:CATX) Given Outperform Rating at WedbushSeptember 17, 2025 | marketbeat.comOppenheimer more confident Perspective’s VMT update will build on prior resultsSeptember 16, 2025 | msn.comPerspective announces first patient dosed in cohort of Phase 1/2a trialSeptember 15, 2025 | msn.comPerspective Therapeutics Progresses Dose Finding for [212Pb]VMT01 in Combination with Nivolumab in its Ongoing Phase 1/2a Study of MC1R-Positive Metastatic MelanomaSeptember 15, 2025 | finance.yahoo.comWalleye Capital LLC Sells 436,402 Shares of Perspective Therapeutics, Inc. $CATXSeptember 8, 2025 | marketbeat.comB. Riley Issues Pessimistic Forecast for CATX EarningsSeptember 7, 2025 | marketbeat.comPerspective Therapeutics Appoints Biotech Veteran Joel Sendek as Chief Financial OfficerSeptember 4, 2025 | markets.businessinsider.comPerspective Therapeutics Appoints Maya Martinez-Davis to Board of DirectorsSeptember 3, 2025 | globenewswire.comPerspective Therapeutics Updates on Radiopharmaceutical AdvancementsSeptember 2, 2025 | tipranks.comNuveen LLC Takes Position in Perspective Therapeutics, Inc. $CATXAugust 31, 2025 | marketbeat.comAffinity Asset Advisors LLC Increases Holdings in Perspective Therapeutics, Inc. $CATXAugust 28, 2025 | marketbeat.comPerspective Therapeutics to Participate in Upcoming September ConferencesAugust 26, 2025 | globenewswire.comBrookline Capital Management Weighs in on CATX Q3 EarningsAugust 23, 2025 | marketbeat.comCATX FY2025 EPS Estimate Reduced by Cantor FitzgeraldAugust 19, 2025 | marketbeat.comWedbush Has Bullish Forecast for CATX Q3 EarningsAugust 19, 2025 | marketbeat.comQ2 Earnings Forecast for CATX Issued By WedbushAugust 17, 2025 | marketbeat.comPerspective Therapeutics Reports Q2 2025 Progress and FinancialsAugust 14, 2025 | msn.comPerspective Therapeutics reports Q2 EPS (29c), consensus (29c)August 13, 2025 | msn.comPerspective Therapeutics Reports Promising Study Results at ASCOAugust 13, 2025 | msn.comPerspective Therapeutics Provides Recent Business Highlights and Reports 2Q 2025 ResultsAugust 13, 2025 | globenewswire.comA Look Ahead: Perspective Therapeutics's Earnings ForecastAugust 12, 2025 | benzinga.comFederated Hermes Inc. Buys Shares of 135,061 Perspective Therapeutics, Inc. (NYSE:CATX)August 11, 2025 | marketbeat.comPerspective Therapeutics, Inc. (NYSE:CATX) Receives Consensus Recommendation of "Buy" from AnalystsAugust 7, 2025 | marketbeat.comPerspective Therapeutics (CATX) Expected to Announce Quarterly Earnings on WednesdayAugust 6, 2025 | marketbeat.comPerspective Therapeutics: Giving Us Some Valuable Perspective On Alpha Emitter TherapyAugust 2, 2025 | seekingalpha.comPerspective Therapeutics Updates Radiopharmaceutical Platform PresentationAugust 2, 2025 | msn.comPerspective Therapeutics, Inc.: Perspective Therapeutics Announces Acceptance of VMT-a-NET Data for Presentation at the ESMO Congress 2025July 25, 2025 | finanznachrichten.dePerspective Therapeutics, Inc. Announces Acceptance of Updated Data for [212Pb]VMT-α-NET Program at ESMO Congress 2025July 24, 2025 | quiverquant.comQPerspective Therapeutics Announces Acceptance of VMT-α-NET Data for Presentation at the ESMO Congress 2025July 24, 2025 | globenewswire.comPerspective Therapeutics (NYSE:CATX) Upgraded at Lifesci CapitalJuly 15, 2025 | marketbeat.comPerspective Therapeutics to Provide Business Highlights and Report Second Quarter 2025 Financial ResultsJuly 15, 2025 | globenewswire.comPerspective Therapeutics, Inc. (NYSE:CATX) Receives Average Recommendation of "Buy" from BrokeragesJuly 13, 2025 | marketbeat.comCATX - Perspective Therapeutics Inc Executives - MorningstarJuly 5, 2025 | morningstar.comMAnalysts Offer Insights on Healthcare Companies: Perspective Therapeutics (CATX), Ocular Therapeutix (OCUL) and Vertex Pharmaceuticals (VRTX)June 25, 2025 | theglobeandmail.comWhat is B. Riley's Estimate for CATX Q2 Earnings?June 24, 2025 | marketbeat.comPerspective Therapeutics (NYSE:CATX) Stock Price Expected to Rise, B. Riley Analyst SaysJune 23, 2025 | marketbeat.comPerspective Therapeutics (NYSE:CATX) Earns Outperform Rating from WedbushJune 23, 2025 | marketbeat.comPerspective Therapeutics Commences Recruitment for [212Pb]VMT-α-NET in the Third Dose Escalation Cohort of its Ongoing Phase 1/2a Clinical TrialJune 21, 2025 | finance.yahoo.comPerspective Therapeutics Presents at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2025 Annual MeetingJune 21, 2025 | globenewswire.com Get Perspective Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CATX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CATX Media Mentions By Week CATX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CATX News Sentiment▼0.270.54▲Average Medical News Sentiment CATX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CATX Articles This Week▼105▲CATX Articles Average Week Get the Latest News and Ratings for CATX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Perspective Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies MDXG News TNDM News BBNX News INMD News IRMD News EMBC News AXGN News CLPT News SIBN News BFLY News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:CATX) was last updated on 10/5/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredU.S. Government Sparking Crypto RallyU.S. Puts GDP on the Blockchain Could this spark the next crypto supercycle? Discover the altcoins poised t...Crypto 101 Media | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredMelt-up warning Porter Stansberry says this bull market is past the “safe zone” and racing toward an event horizon — and in hi...Porter & Company | SponsoredThe Coin That Could Define Trump’s Crypto PresidencyWhen Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top ad...Weiss Ratings | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Perspective Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Perspective Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
